Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Effects of the Timing of Vagus Nerve Stimulation Combined With Exercise in Chronic Neck Pain

12. august 2026 oppdatert av: Ismail Saracoglu, Kutahya Health Sciences University

Does Timing Matter? Effects of Transcutaneous Auricular Vagus Nerve Stimulation Before and After Exercise in Chronic Neck Pain: A Randomized Controlled Trial

This randomized controlled trial aims to investigate whether the timing of transcutaneous auricular vagus nerve stimulation (taVNS) relative to exercise influences clinical and autonomic outcomes in individuals with chronic neck pain.

Participants will be randomly allocated to one of three groups: taVNS applied before exercise, taVNS applied after exercise, or exercise alone. All groups will receive a standardized exercise program designed for chronic neck pain. The intervention will be conducted over a 6- to 8-week period.

The effects of the interventions will be evaluated using pain intensity, neck-related disability, sleep quality, heart rate variability, and exercise adherence. The study will determine whether applying taVNS before or after exercise provides additional benefits compared with exercise alone and whether the timing of stimulation influences treatment outcomes.

Studieoversikt

Detaljert beskrivelse

Chronic neck pain is a common musculoskeletal condition associated with pain, functional limitations, sleep disturbances, and alterations in autonomic nervous system activity. Exercise therapy is one of the main conservative treatment approaches for chronic neck pain. Transcutaneous auricular vagus nerve stimulation (taVNS) is a non-invasive neuromodulation method that aims to stimulate the auricular branch of the vagus nerve and may influence parasympathetic activity and pain modulation.

The purpose of this randomized controlled trial is to investigate whether the timing of taVNS relative to exercise influences clinical and physiological outcomes in individuals with chronic neck pain.

A total of 81 participants with chronic neck pain will be randomly allocated to three parallel groups. Participants in the first group will receive taVNS before performing a standardized exercise program. Participants in the second group will perform the same exercise program followed by taVNS. Participants in the control group will receive the exercise program alone.

The exercise program will include postural correction exercises, deep cervical flexor activation exercises, cervical mobility exercises, scapular stabilization exercises, and stretching exercises. The intervention period will last approximately 6-8 weeks.

Participants will be evaluated before and after the intervention period. Pain intensity will be assessed using the Numeric Pain Rating Scale, neck-related disability using the Neck Disability Index, sleep quality using the Pittsburgh Sleep Quality Index, and autonomic nervous system activity using heart rate variability, particularly the root mean square of successive differences (RMSSD). Exercise adherence and session attendance will also be recorded.

The study will compare changes in these outcomes among the three groups to determine whether the timing of taVNS relative to exercise influences the effectiveness of rehabilitation in individuals with chronic neck pain.

Studietype

Intervensjonell

Registrering (Antatt)

81

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

    • Türkiye
      • Kütahya, Türkiye, Tyrkia (Türkiye), 43100
        • Kutahya Health Sciences University Physical Therapy and Rehabilitation Research Center
        • Underetterforsker:
          • Merve Akdeniz LEBLEBİCİER, MD
        • Ta kontakt med:
        • Hovedetterforsker:
          • Batuhan YUKSEL, Msc.

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Nei

Beskrivelse

Inclusion Criteria:

  • Diagnosis of chronic neck pain confirmed by a physical medicine and rehabilitation physician.
  • Age between 18 and 65 years.
  • Neck pain persisting or recurring for at least 3 months.
  • Ability to participate in the exercise program included in the study protocol.
  • No contraindication to transcutaneous auricular vagus nerve stimulation.
  • Willingness to provide written informed consent.
  • Willingness to participate regularly in the planned exercise and assessment sessions.

Exclusion Criteria:

  • Cervical radiculopathy or specific neurological findings.
  • Previous cervical spine surgery.
  • Serious cardiovascular disease.
  • Serious neurological or systemic disease.
  • Pregnancy.
  • Orthopedic or musculoskeletal conditions preventing participation in exercise.
  • Cognitive or communication problems that prevent completion of the assessment instruments.
  • Inability or unwillingness to comply with the study protocol or attend scheduled sessions.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Dobbelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: taVNS Before Exercise
Participants will receive transcutaneous auricular vagus nerve stimulation before performing the standardized exercise program.
Transcutaneous auricular vagus nerve stimulation will be delivered non-invasively through an auricular stimulation device targeting the auricular branch of the vagus nerve. Stimulation will be administered under researcher supervision using standardized stimulation parameters according to the device instructions and study protocol.
Participants will perform a standardized exercise program for chronic neck pain including postural correction, deep cervical flexor activation, cervical mobility, scapular stabilization, and stretching exercises. Exercises will be performed under researcher supervision during the intervention period.
Eksperimentell: taVNS After Exercise
Participants will first perform the standardized exercise program and will subsequently receive transcutaneous auricular vagus nerve stimulation.
Transcutaneous auricular vagus nerve stimulation will be delivered non-invasively through an auricular stimulation device targeting the auricular branch of the vagus nerve. Stimulation will be administered under researcher supervision using standardized stimulation parameters according to the device instructions and study protocol.
Participants will perform a standardized exercise program for chronic neck pain including postural correction, deep cervical flexor activation, cervical mobility, scapular stabilization, and stretching exercises. Exercises will be performed under researcher supervision during the intervention period.
Aktiv komparator: Exercise only
Participants will receive the standardized exercise program without transcutaneous auricular vagus nerve stimulation.
Participants will perform a standardized exercise program for chronic neck pain including postural correction, deep cervical flexor activation, cervical mobility, scapular stabilization, and stretching exercises. Exercises will be performed under researcher supervision during the intervention period.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in Pain Intensity - Numeric Pain Rating Scale
Tidsramme: Baseline and immediately after completion of the 6 week interventions
Pain intensity will be assessed using the Numeric Pain Rating Scale (NPRS). Participants will rate their neck pain on an 11-point scale ranging from 0 to 10, where 0 indicates "no pain" and 10 indicates "worst imaginable pain." Higher scores indicate greater pain intensity. Change from baseline will be compared between groups.
Baseline and immediately after completion of the 6 week interventions
Change in Neck-Related Disability - Neck Disability Index
Tidsramme: Baseline and immediately after completion of the 6 weeks interventions.
Neck-related disability will be assessed using the Neck Disability Index (NDI). The questionnaire consists of 10 sections scored from 0 to 5, producing a total score ranging from 0 to 50. Higher scores indicate greater neck-related disability.
Baseline and immediately after completion of the 6 weeks interventions.
Change in Sleep Quality - Pittsburgh Sleep Quality Index
Tidsramme: Baseline and immediately after completion of the 6 weeks intervention.
Sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI). The PSQI evaluates seven components of sleep and provides a global score ranging from 0 to 21. Higher scores indicate poorer sleep quality.
Baseline and immediately after completion of the 6 weeks intervention.

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Exercise Adherence
Tidsramme: Throughout the 6-8-week intervention period.
Exercise adherence will be assessed based on participant attendance at scheduled treatment sessions. Adherence will be expressed as the number and/or percentage of completed sessions relative to the total number of planned sessions.
Throughout the 6-8-week intervention period.
Change in Heart Rate Variability - RMSSD
Tidsramme: Baseline and immediately after completion of the 6 weeks intervention.
Autonomic nervous system activity will be assessed using heart rate variability. The root mean square of successive differences between normal heartbeats (RMSSD), expressed in milliseconds, will be used as the primary heart rate variability parameter. Higher RMSSD values generally represent greater parasympathetic/vagal activity.
Baseline and immediately after completion of the 6 weeks intervention.

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

14. september 2026

Primær fullføring (Antatt)

30. juni 2027

Studiet fullført (Antatt)

15. september 2027

Datoer for studieregistrering

Først innsendt

12. august 2026

Først innsendt som oppfylte QC-kriteriene

12. august 2026

Først lagt ut (Faktiske)

17. august 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

17. august 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

12. august 2026

Sist bekreftet

1. august 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere